Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development FIS Q1 2026 Earnings EPS Beats Estimates by 464 as Profitability Takes Center Stage Innovative Solutions and Support Inc ISSC Q1 2026 Earnings EPS Smashes Estimates by 477 as Shares Slip Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses VEON Q1 2026 Earnings Earnings Beat Expectations Despite Lack of Revenue Disclosure FIS Q1 2026 Earnings EPS Surpasses Estimates by 464 as Stock Moves Lower